TY  - RPRT
TI  - Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection.
AU  - Austin D Williams
AU  - Anna Weiss
PY  - 2026
DO  - 10.1002/cncr.70587
UR  - https://pubmed.ncbi.nlm.nih.gov/42667265/
ID  - 42667265
ER  -